Psyched Wellness (5U9) Stock Price & Analysis

1 Followers

5U9 Stock Chart & Stats

€0.01-€0.00(-16.67%)

At close: Apr 21 2:00 AM GMT+2

Day’s Range: EUR 0.01 - EUR 0.01
52-Week Range: EUR 0.00 - EUR 0.02
Previous Close: EUR 0.01
Volume: N/A
Average Volume (3M): 27.39K
Market Cap: EUR 1.30M
Enterprise Value: EUR 2.14M
Total Cash (Recent Filing): EUR 182.51K
Total Debt (Recent Filing): EUR 288.13K
Price to Earnings (P/E): ―
Beta: -0.82
Next Earnings: Apr 01, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Revenue growth shows that the company is gaining commercial traction and expanding sales beyond its initial base. If this trajectory continues, greater scale could improve operating leverage and provide a foundation for better economics, although profitability must still catch up.

Low Leverage

Low leverage reduces immediate balance-sheet pressure and limits the burden of interest obligations while the company develops its products. This provides more financial flexibility than a highly indebted structure, although continued losses could still require outside funding.

Defined Wellness Product Focus

A focused product strategy centered on standardized Amanita-derived ingredients gives the company a clear direction across nutraceutical and natural health markets. Concentrated expertise in extraction, formulation, and consumer products may support consistent development over the medium term.

Bears Say

Negative Gross Profit And Large Losses

Negative gross profit indicates that the current revenue base does not yet cover direct product costs, before broader operating expenses are considered. Persistently large operating and net losses weaken the path to self-funded growth and raise questions about the sustainability of the business model.

Persistent Cash Burn

Ongoing negative operating and free cash flow means the company is not currently funding operations from internally generated cash. Worsening TTM free cash flow increases dependence on external financing and could constrain investment, product development, and execution if losses persist.

Shrinking Equity And Balance-Sheet Flexibility

Declining equity and assets reflect accumulated losses and reduce the financial cushion available to support operations. Deeply negative returns on equity also indicate value erosion for shareholders, while a smaller balance sheet can limit flexibility and increase reliance on future financing.

Psyched Wellness News

Psyched Wellness Secures US$134,000 Loan for AMA Operations

Psyched Wellness ( ($TSE:PSYC) ) has issued an update. Psyched Wellness is a Canadian life sciences and health supplements company focused on producing and distributing Amanita Muscaria-derived products, mushroom-based supplements

1h ago5U9 PSYCF

Psyched Wellness Secures Related-Party Term Loan to Fund AMA Brand Operations

The latest announcement is out from Psyched Wellness ( ($TSE:PSYC) ). Psyched Wellness has secured a US$110,577 term loan from Gotham Green funds, which will be used to fund operating

4w ago5U9 PSYCF

Psyched Wellness Secures Insider-Backed Term Loan to Fund AMA Brand Growth

Psyched Wellness ( ($TSE:PSYC) ) has shared an update. Psyched Wellness has secured US$230,000 in term notes from Gotham Green Fund III entities to fund operating expenses and inventory purchases

3M ago5U9 PSYCF

Psyched Wellness Raises Capital, Settles Debt in Shares and Tightens Ties With Lead Investor

Psyched Wellness ( ($TSE:PSYC) ) has shared an update. Psyched Wellness has closed the first tranche of a non-brokered private placement, raising roughly C$860,000 through the issuance of common shares

7M ago5U9 PSYCF

Psyched Wellness Secures Strategic Private Placement Led by Gotham Green

Psyched Wellness ( ($TSE:PSYC) ) has issued an update. Psyched Wellness has entered into a non-binding term sheet with Gotham Green funds for a non-brokered private placement of common shares

8M ago5U9 PSYCF

Psyched Wellness Sells Out First Run of Calmer and Ramps Up Production

Psyched Wellness ( ($TSE:PSYC) ) has shared an announcement. Psyched Wellness has sold out the initial production run of its new double-strength relaxation product, Calmer, which is formulated with the

9M ago5U9 PSYCF

Psyched Wellness Unveils Potent New Product ‘Calmer’ and Enhances ‘Calm’

Psyched Wellness ( ($TSE:PSYC) ) has provided an update. Psyched Wellness has launched ‘Calmer,’ a new product that offers twice the potency of its flagship product, ‘Calm,’ and has improved

11M ago5U9 PSYCF

Psyched Wellness Announces Product Launches and Regulatory Updates

An update from Psyched Wellness ( ($TSE:PSYC) ) is now available. Psyched Wellness has provided an investor update detailing significant progress in product development, scientific studies, and regulatory compliance. The

1y ago5U9 PSYCF

Psyched Wellness Completes Pilot Run for New Dietary Supplement

Psyched Wellness ( ($TSE:PSYC) ) has issued an announcement. Psyched Wellness Ltd. announced the completion of an initial pilot run for a new dietary supplement shot through its US subsidiary,

1y ago5U9 PSYCF

Psyched Wellness Announces Genotoxicity Study and Strategic Developments

Psyched Wellness ( ($TSE:PSYC) ) has provided an update. Psyched Wellness has announced a series of corporate updates, including the initiation of a Genotoxicity Study on its proprietary Amanita Muscaria

1y ago5U9 PSYCF

5U9 FAQ

What was Psyched Wellness’s price range in the past 12 months?

Psyched Wellness lowest stock price was €0.00 and its highest was €0.02 in the past 12 months.

What is Psyched Wellness’s market cap?

Psyched Wellness’s market cap is €1.30M.

When is Psyched Wellness’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Psyched Wellness’s earnings last quarter?

Psyched Wellness released its earnings results on Oct 30, 2026. The company reported -€0.002 earnings per share for the quarter.

Is Psyched Wellness overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Psyched Wellness pay dividends?

Psyched Wellness does not currently pay dividends.

What is Psyched Wellness’s EPS estimate?

Psyched Wellness’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Psyched Wellness have?

Psyched Wellness has 407,715,850 shares outstanding.

What happened to Psyched Wellness’s price movement after its last earnings report?

Psyched Wellness reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Psyched Wellness?

Currently, no hedge funds are holding shares in DE:5U9

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description